Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma
PurposeThe aim of this study was to develop a comprehensive differential gene profile for hepatocellular carcinoma (HCC) patients treated with sorafenib.MethodsThe RNA sequencing data and miRNA sequencing data of 114 HCC patients treated with sorafenib only and 326 HCC control patients treated witho...
Main Authors: | Huancheng Wang, Jia Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2020.577000/full |
Similar Items
-
Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma
by: Sojung Han, et al.
Published: (2020-07-01) -
Sorafenib for Egyptian patients with advanced hepatocellular carcinoma; single center experience
by: Omar Abdel-Rahman, et al.
Published: (2014-03-01) -
Sorafenib in the treatment of advanced hepatocellular carcinoma
by: Mousa Ali
Published: (2008-01-01) -
Identification of immune-related genes for Hepatocellular Carcinoma: a study based on TCGA data
by: Chun-Bo Li, et al.
Published: (2021-04-01) -
Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells
by: Yeonghoon Son, et al.
Published: (2021-05-01)